KANNAPOLIS, NC, June 1, 2021 — Salubrent Pharma Solutions, Inc. (“SPS”), a technology-focused Contract Development and Manufacturing Organization (CDMO) and Bright Path Laboratories (“BPL”), a leader in continuous-flow reactor technology, have entered into a strategic partnership agreement whereby SPS will be the exclusive provider of analytical testing services to BPL.
Furthermore, SPS will co-locate with BPL to allow SPS to provide these services rapidly for BPL and other SPS pharmaceutical and biotech customers. SPS will equip their new analytical laboratory in BPL’s Kannapolis, NC facility with 1,500 sq. ft. of lab space and 1,000 sq. ft. of walk-in stability chamber space built to meet cGMP standards. In addition to stability services, SPS will offer a comprehensive range of analytical testing services, including ELISA immunoassay testing.
“Partnering with Bright Path Labs allows us to quickly establish Salubrent’s analytical services business and begin serving customers within the next few months,” said Terry Novak, Salubrent’s President and CEO, “in addition, it serves to officially launch Salubrent Pharma Solution’s first service offering as we continue to raise funds to build out our flexible, small batch sterile fill & finish facility.”
John Allen, Bright Path’s Chief Commercial Officer added, “Salubrent’s mission and ability to rapidly provide just-in-time (“JIT”) micro-batch sterile fill & finish services aligns perfectly with Bright Path’s mission and ability to produce JIT small batch active pharmaceutical ingredients for its clients who need products on-demand. We’re looking forward to a long and productive partnership with Salubrent.”
About Salubrent Pharma Solutions
Salubrent Pharma Solutions is a contract development and manufacturing organization (CDMO) that offers comprehensive analytical services to clinical and commercial stage pharma and biotech companies. We will soon begin construction of our first state-of-the-art fill & finish facility to offer flexible aseptic solutions and related formulation development and analytical expertise to those companies in need of small batch production of sterile injectable products. Learn more at salubrent.com
About Bright Path Laboratories, Inc.
Bright Path Labs is a pharmaceutical innovation company focused on reducing drug development cycle times and direct scaling of manufacturing processes for drug substance commercialization. The company deploys its cutting-edge, proprietary continuous-flow platform for chemical synthetic route optimization using green chemistry and then offers development, clinical, and high throughput commercial production applications augmented with advanced closed-loop control for continual process verification. For more information, visit brightpathlabs.com